372 related articles for article (PubMed ID: 36601121)
1. The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma.
Zhou W; Xu X; Cen Y; Chen J
Front Immunol; 2022; 13():1085766. PubMed ID: 36601121
[TBL] [Abstract][Full Text] [Related]
2. The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment.
Guo Y; Xie Y; Luo Y
Front Immunol; 2022; 13():851004. PubMed ID: 35222443
[TBL] [Abstract][Full Text] [Related]
3. Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma.
Lin K; Zhou Y; Lin Y; Feng Y; Chen Y; Cai L
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189408
[TBL] [Abstract][Full Text] [Related]
4. The involvement of lncRNAs in the development and progression of pancreatic cancer.
Duguang L; Jin H; Xiaowei Q; Peng X; Xiaodong W; Zhennan L; Jianjun Q; Jie Y
Cancer Biol Ther; 2017 Dec; 18(12):927-936. PubMed ID: 29053398
[TBL] [Abstract][Full Text] [Related]
5. The role of lncRNAs and exosomal lncRNAs in cancer metastasis.
Zhang Y; Zhao L; Bi Y; Zhao J; Gao C; Si X; Dai H; Asmamaw MD; Zhang Q; Chen W; Liu H
Biomed Pharmacother; 2023 Sep; 165():115207. PubMed ID: 37499455
[TBL] [Abstract][Full Text] [Related]
6. The landscape of long non-coding RNAs in tumor stroma.
Uddin MN; Wang X
Life Sci; 2021 Jan; 264():118725. PubMed ID: 33166593
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
Drak Alsibai K; Meseure D
Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
[TBL] [Abstract][Full Text] [Related]
8. Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process.
Melixetian M; Pelicci PG; Lanfrancone L
Cells; 2022 Feb; 11(3):. PubMed ID: 35159386
[TBL] [Abstract][Full Text] [Related]
9. The emerging co-regulatory role of long noncoding RNAs in epithelial-mesenchymal transition and the Warburg effect in aggressive tumors.
Hua Q; Mi B; Huang G
Crit Rev Oncol Hematol; 2018 Jun; 126():112-120. PubMed ID: 29759552
[TBL] [Abstract][Full Text] [Related]
10. Identification of Epithelial Mesenchymal Transition-Related lncRNAs Associated with Prognosis and Tumor Immune Microenvironment of Hepatocellular Carcinoma.
Zhou Y; Wang L; Zhang W; Ma J; Zhang Z; Yang M; Yu J; Luo J; Yan Z
Dis Markers; 2022; 2022():6335155. PubMed ID: 35111268
[TBL] [Abstract][Full Text] [Related]
11. Pan-sarcoma characterization of lncRNAs in the crosstalk of EMT and tumour immunity identifies distinct clinical outcomes and potential implications for immunotherapy.
Shi D; Mu S; Pu F; Zhong B; Hu B; Muhtar M; Tong W; Shao Z; Zhang Z; Liu J
Cell Mol Life Sci; 2022 Jul; 79(8):427. PubMed ID: 35842562
[TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA and Epithelial Mesenchymal Transition in Cancer.
Gugnoni M; Ciarrocchi A
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003545
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNAs in melanoma.
Yu X; Zheng H; Tse G; Chan MT; Wu WK
Cell Prolif; 2018 Aug; 51(4):e12457. PubMed ID: 29582492
[TBL] [Abstract][Full Text] [Related]
14. Function and Clinical Implications of Long Non-Coding RNAs in Melanoma.
Richtig G; Ehall B; Richtig E; Aigelsreiter A; Gutschner T; Pichler M
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28350340
[TBL] [Abstract][Full Text] [Related]
15. Involvement of long non-coding RNAs in the progression of esophageal cancer.
Xue W; Zheng Y; Shen Z; Li L; Fan Z; Wang W; Zhu Z; Zhai Y; Zhao J; Kan Q
Cancer Commun (Lond); 2021 May; 41(5):371-388. PubMed ID: 33605567
[TBL] [Abstract][Full Text] [Related]
16. Identification of Prognostic lncRNA Related to the Immune Microenvironment of Soft Tissue Sarcoma.
Dai WY; Wang B; Li JY; Luo ZP
Biomed Res Int; 2022; 2022():9471558. PubMed ID: 35155682
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA loss in immune suppression in cancer.
Hu Q; Egranov SD; Lin C; Yang L
Pharmacol Ther; 2020 Sep; 213():107591. PubMed ID: 32473960
[TBL] [Abstract][Full Text] [Related]
18. Development of epithelial-mesenchymal transition-related lncRNA signature for predicting survival and immune microenvironment in pancreatic cancerwithexperiment validation.
Gao Y; Liu J; Cai B; Chen Q; Wang G; Lu Z; Jiang K; Miao Y
Bioengineered; 2021 Dec; 12(2):10553-10567. PubMed ID: 34854360
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA regulation of epithelial-mesenchymal transition in cancer metastasis.
Xu Q; Deng F; Qin Y; Zhao Z; Wu Z; Xing Z; Ji A; Wang QJ
Cell Death Dis; 2016 Jun; 7(6):e2254. PubMed ID: 27277676
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNAs as regulators of cancer immunity.
Denaro N; Merlano MC; Lo Nigro C
Mol Oncol; 2019 Jan; 13(1):61-73. PubMed ID: 30499165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
